Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-Arm, Open-Label, Exploratory Study to Evaluate Safety and Efficacy of LM103 Injection in the Treatment of Advanced Solid Tumors

NCT05366478 is registered in ClinicalTrials.gov with Suzhou BlueHorse Therapeutics Co., Ltd. as lead sponsor.

NCT NCT05366478
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05366478 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-Arm, Open-Label, Exploratory Study to Evaluate Safety and Efficacy of LM103 Injection in the Treatment of Advanced Solid Tumors
Lead sponsor
Suzhou BlueHorse Therapeutics Co., Ltd.
Phase
Phase 1
Overall status
Recruiting
Start date
May 30, 2022
Completion date
May 30, 2029
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervical carcinoma, melanoma, non small cell lung cancer